These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8644398)

  • 1. [Can magnetic resonance imaging differentiate between benign and malignant conditions in patients with skeletal or soft tissue tumors?].
    Lundorf E; Keller JO; Nielsen OS; Jensen OM; Christensen T
    Ugeskr Laeger; 1996 Mar; 158(11):1518-20. PubMed ID: 8644398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions.
    Moulton JS; Blebea JS; Dunco DM; Braley SE; Bisset GS; Emery KH
    AJR Am J Roentgenol; 1995 May; 164(5):1191-9. PubMed ID: 7717231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases].
    Falaschi F; Battolla L; Zampa V; Cioni R; Cambi L; Antonelli A; Bartolozzi C
    Radiol Med; 1996 Dec; 92(6):713-8. PubMed ID: 9122459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and imaging of bone and soft-tissue sarcomas.
    Ilaslan H; Schils J; Nageotte W; Lietman SA; Sundaram M
    Cleve Clin J Med; 2010 Mar; 77 Suppl 1():S2-7. PubMed ID: 20179183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and diagnostic significance of fluid-fluid levels in soft-tissue neoplasms.
    Alyas F; Lee J; Ahmed M; Connell D; Saifuddin A
    Clin Radiol; 2007 Aug; 62(8):769-74; discussion 775. PubMed ID: 17604765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking orbital imaging establishing guidelines for interpreting orbital imaging studies and evaluating their predictive value in patients with orbital tumors.
    Ben Simon GJ; Annunziata CC; Fink J; Villablanca P; McCann JD; Goldberg RA
    Ophthalmology; 2005 Dec; 112(12):2196-207. PubMed ID: 16325712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MR imaging of bone and soft tissue tumors].
    Nishimura H; Koganemaru M; Uchida M; Ohtake H; Nakashima M
    Rinsho Hoshasen; 1990 Jan; 35(1):57-68. PubMed ID: 2313923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Staging and re-staging of soft tissue sarcoma using MRI. Usefulness of contrast media].
    Barile A; Caulo M; Zugaro L; Di Cesare E; Gallucci M; Masciocchi C
    Radiol Med; 2001 Jun; 101(6):444-55. PubMed ID: 11479441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign versus malignant compression fracture: a diagnostic accuracy of magnetic resonance imaging.
    Pongpornsup S; Wajanawichakorn P; Danchaivijitr N
    J Med Assoc Thai; 2009 Jan; 92(1):64-72. PubMed ID: 19260246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of core needle biopsy in the diagnosis of suspected soft tissue tumours.
    Strauss DC; Qureshi YA; Hayes AJ; Thway K; Fisher C; Thomas JM
    J Surg Oncol; 2010 Oct; 102(5):523-9. PubMed ID: 20872955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings.
    Pilleul F; Rochette A; Partensky C; Scoazec JY; Bernard P; Valette PJ
    J Magn Reson Imaging; 2005 Mar; 21(3):237-44. PubMed ID: 15723374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of soft-tissue masses: the relationship between lesion size, depth, and diagnosis.
    Datir A; James SL; Ali K; Lee J; Ahmad M; Saifuddin A
    Clin Radiol; 2008 Apr; 63(4):373-8; discussion 379-80. PubMed ID: 18325355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions.
    Berquist TH; Ehman RL; King BF; Hodgman CG; Ilstrup DM
    AJR Am J Roentgenol; 1990 Dec; 155(6):1251-5. PubMed ID: 2122675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
    Booth SJ; Turnbull LW; Poole DR; Richmond I
    BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging in the diagnosis and local staging of primary bone tumors.
    Rafique MZ; Bari V
    J Coll Physicians Surg Pak; 2004 Jan; 14(1):10-3. PubMed ID: 14764253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
    Orel SG; Rosen M; Mies C; Schnall MD
    Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign and malignant soft tissue mass: magnetic resonance imaging criteria for discrimination.
    Kalayanarooj S
    J Med Assoc Thai; 2008 Jan; 91(1):74-81. PubMed ID: 18386548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-treatment complications of soft tissue tumours.
    Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
    Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions.
    Balliu E; Vilanova JC; Peláez I; Puig J; Remollo S; Barceló C; Barceló J; Pedraza S
    Eur J Radiol; 2009 Mar; 69(3):560-6. PubMed ID: 18276098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.